e-learning
resources
London 2016
Tuesday, 06.09.2016
Epidemiological and clinical data regarding the modern management of chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of intratracheal dilation – Injection technique in treatment of granulomatosis with polyangiitis (GPA) patients with subglottic stenosis
Justyna Fijołek (Warsaw, Poland), Justyna Fijolek, Elzbieta Wiatr, Dariusz Gawryluk, Magdalena Maria Martusewicz-Boros, Tadeusz Maria Orlowski, Dariusz Dziedzic, Malgorzata Polubiec-Kownacka, Karina Oniszh, Renata Langfort, Kazimierz Roszkowski-Sliz
Source:
International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Session:
Epidemiological and clinical data regarding the modern management of chronic lung diseases
Session type:
Poster Discussion
Number:
3548
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Justyna Fijołek (Warsaw, Poland), Justyna Fijolek, Elzbieta Wiatr, Dariusz Gawryluk, Magdalena Maria Martusewicz-Boros, Tadeusz Maria Orlowski, Dariusz Dziedzic, Malgorzata Polubiec-Kownacka, Karina Oniszh, Renata Langfort, Kazimierz Roszkowski-Sliz. The role of intratracheal dilation – Injection technique in treatment of granulomatosis with polyangiitis (GPA) patients with subglottic stenosis. Eur Respir J 2016; 48: Suppl. 60, 3548
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Management of subglottic stenosis (sgs) with endoscopic procedures in patients with Wegener‘s granulomatosis
Source: Annual Congress 2009 - How to deal with tracheal stenosis
Year: 2009
Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis
Source: Eur Respir Rev 2008; 17: 30-32
Year: 2008
ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Granulomatosis with polyangiitis (Wegener&s)
Source: Eur Respir Mon 2011; 54: 1-14
Year: 2011
Laser treatment of Wegeners granulomatosis (WG) located in trachea and main bronchii
Source: Eur Respir J 2001; 18: Suppl. 33, 393s
Year: 2001
Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (1) 00311-2019; 10.1183/23120541.00311-2019
Year: 2020
Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis
Source: International Congress 2019 – Pulmonary vascular diseases?
Year: 2019
Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener‘s granulomatosis
Source: Annual Congress 2007 - Interventional bronchoscopy
Year: 2007
Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases
Source: International Congress 2014 – ILDs 6
Year: 2014
Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 38: 1081-1088
Year: 2011
Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis
Source: Eur Respir J 2010; 36: 116-121
Year: 2010
Effectiveness of rituximab (RTX) therapy in recurrent granulomatosis with polyangiitis (GPA)
Source: International Congress 2016 – New and old therapies for chronic lung diseases
Year: 2016
Sublottic stenosis in the course of Wegener's granulomatosis- the role of additional intratracheal therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 64s
Year: 2002
Combined pulmonary fibrosis and emphysema associated with microscopic polyangiitis
Source: Eur Respir J 2012; 40: 505-507
Year: 2012
Involvement of the respiratory tract in granulomatosis with polyangiitis - bronchoscopic point of view
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020
Year: 2020
Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome)
Source: Eur Respir J, 57 (5) 2004158; 10.1183/13993003.04158-2020
Year: 2021
Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept